1. Home
  2. ELBM vs PMVP Comparison

ELBM vs PMVP Comparison

Compare ELBM & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electra Battery Materials Corporation

ELBM

Electra Battery Materials Corporation

HOLD

Current Price

$0.51

Market Cap

60.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.10

Market Cap

66.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELBM
PMVP
Founded
2011
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.9M
66.1M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ELBM
PMVP
Price
$0.51
$1.10
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.15
N/A
AVG Volume (30 Days)
302.6K
300.8K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$28.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$1.02
52 Week High
$8.70
$1.88

Technical Indicators

Market Signals
Indicator
ELBM
PMVP
Relative Strength Index (RSI) 40.13 38.21
Support Level $0.50 $1.07
Resistance Level $0.60 $1.26
Average True Range (ATR) 0.03 0.09
MACD -0.00 -0.02
Stochastic Oscillator 7.67 0.71

Price Performance

Historical Comparison
ELBM
PMVP

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry. The Company's operating segments are Refinery, Exploration and Evaluation, Corporate and Other.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: